genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. The Pharmacogenomic Services division offers molecular measures of biological processes. The Diagnostics division is involved in commercializing the Genedrive point of need molecular testing platform. It serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is based in Manchester, the United Kingdom.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Phone+44-161-9890245
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees72
OptionableNot Optionable
Genedrive (LON:GDR) Frequently Asked Questions
What is Genedrive's stock symbol?
Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."
How were Genedrive's earnings last quarter?
Genedrive PLC (LON:GDR) released its quarterly earnings results on Tuesday, March, 20th. The company reported ($9.00) EPS for the quarter. The business earned $2.63 million during the quarter. View Genedrive's Earnings History.
What price target have analysts set for GDR?
0 brokerages have issued 12-month price objectives for Genedrive's shares. Their forecasts range from GBX 152 to GBX 152. On average, they anticipate Genedrive's stock price to reach GBX 152 in the next twelve months. This suggests a possible upside of 560.9% from the stock's current price. View Analyst Price Targets for Genedrive.
Has Genedrive been receiving favorable news coverage?
Media stories about GDR stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Genedrive earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are some of Genedrive's key competitors?
Some companies that are related to Genedrive include BioMark Diagnostics (BUX), BioNano Genomics (BNGOU), Breathtec Biomedical (BTH), Cambridge Cognition (COG), Carl Data Solutions (CRL), Carl Zeiss Meditec (AFX), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), MaxCyte (MXCT), Medical Imaging (MEDD), Oncimmune (ONC), Parallax Health Sciences (PRLX) and Profound Medical (PRN).
Who are Genedrive's key executives?
Genedrive's management team includes the folowing people:
- Mr. David Budd, CEO & Director (Age 51)
- Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 44)
How do I buy shares of Genedrive?
Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genedrive's stock price today?
One share of GDR stock can currently be purchased for approximately GBX 23.
What is Genedrive's official website?
How can I contact Genedrive?
Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245.
MarketBeat Community Rating for Genedrive (LON GDR)
MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
